Cyrus Karkaria, PhD
Advertisement
Dr. Cyrus Karkaria is President of Lupin's Biotechnology Businesses, leading the company's global biosimilars portfolio with over 30 years of biologic drug development experience at organizations including Biogen, CuraGen, and Celldex Therapeutics. He holds a post-doctorate from Harvard Medical School and a PhD. from the University of Maryland.
Articles by Cyrus Karkaria, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves subcutaneous Enspryng for TED
2
OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant
3
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
4
EC-104 outperforms Ozurdex in phase 2 BETTIS-1 trial for anti-VEGF–resistant DME
5